top of page
News, Events and Updates
Search
Anavex Life Sciences to Present at the 22nd Annual Needham Virtual Healthcare Conference 2023
Apr 10, 2023
ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48Week Phase 2 Extension Study in PDD
Mar 30, 2023
Anavex Life Sciences Appoints Former FDA Lead Neurology Statistician as VP Head of Biostatistics
Mar 9, 2023
Anavex Life Sciences Reports Fiscal 2023 First Quarter Financial Results
Feb 7, 2023
Anavex Life Sciences Announces Exceeding of Enrollment Target for ANAVEX®2-73 (blarcamesine)
Feb 2, 2023
Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on February 7, 2023
Jan 31, 2023
Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial
Dec 14, 2022
Anavex Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Dec 12, 2022
Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022
Dec 2, 2022
7
8
9
10
11
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
